Synthesis, characterization and in vitro antitumor activity of di- and triorganotin derivatives of polyoxa- and biologically relevant carboxylic acids

Journal of Inorganic Biochemistry

Volumn 79, Issue 1-4, 2000, Pages 139-145

  Gielen, Marcel ^a   Biesemans, Monique ^a   De Vos, Dick ^b   Willem, Rudolph ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b TEVA Pharmachemie   (Netherlands)

Author keywords

Antitumor activity; Carboxylic acids; Organotin derivatives

Indexed keywords

CARBOXYLIC ACID DERIVATIVE; DOXORUBICIN; ORGANOTIN COMPOUND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN;

ANTINEOPLASTIC AGENTS; CARBOXYLIC ACIDS; CELL SURVIVAL; DRUG DESIGN; HUMANS; MODELS, MOLECULAR; ORGANOTIN COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0034732642     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(99)00161-0     Document Type: Article

References (47)

1. Loehrer P.J., Einhorn L.H. Ann. Intern. Med. 100:1984;704.
2. Comis R.L. Sem. Oncol. 21(suppl. 12):1994;109.
3. Ruckdeschel J.C. Sem. Oncol. 21(suppl. 12):1994;114.
4. Weiss R.B., Christian M.C. Drugs. 46:1993;360.
5. Lippert B. Coord. Chem. Rev. 182:1999;263.
6. Berghoff U., Schmidt K., Janik M., Schröder G., Lippert B. Inorg. Chim. Acta. 269:1998;135.
7. Matsumoto K., Noguchi Y., Yoshida N. Inorg. Chim. Acta. 272:1998;162.
8. Choi S., Filotto C., Bisanzo M., Delaney S., Lagasee D., Whitworth J.L., Jusko A., Li C., Wood N.A., Willingham J., Schwenker A., Spaulding K. Inorg. Chem. 37:1998;2500.
9. Hay R.W., Miller S. Polyhedron. 17:1998;2337.
10. Quiroga A.G., Pérez J.M., Lopez-Solera I., Montero E.I., Masaguer J.R., Alonso C., Navarro-Ranninger C. J. Inorg. Biochem. 69:1998;275.
11. Quiroga A.G., Pérez J.M., Lopez-Solera I., Montero E.I., Masaguer J.R., Alonso C., Navarro-Ranninger C. J. Inorg. Biochem. 70:1998;117.
12. Shamsuddin S., Santillan C.C., Stark J.L., Whitmire K.H., Siddik Z.H., Khokhar A.R. J. Inorg. Biochem. 71:1998;29.
13. Talman E.G., Kidami Y., Mohrmann L., Reedijk J. Inorg. Chim. Acta. 283:1998;251.
14. Y. Chen, Z. Guo, J.A. Parkinson, P.J. Sadler, J. Chem. Soc., Dalton Trans. (1998) 3577.
15. Yuriev E., Orbell J.D. Inorg. Chem. 37:1998;6269.
16. Raiski S.R., Williams R.M. Chem. Rev. 98:1998;2723.
17. Kurbacher C.M., Mallmann P., Kurbacher J.A., Sass G., Andreotti P.E., Rahmun A., Hubner H., Krebs D. Anticancer Res. 14:1994;1961.
18. M.R. Boyd, in: V.T. de Vita Jr., S. Hellman, S.A. Rosenberg (Eds.), Principles and Practice of Oncology Updates, vol. 3, J.B. Lippincott Co., Philadelphia, 1989, pp. 1, 10.
19. Boyd M.R., Paull K.D. Drug Dev. Res. 34:1995;91.
20. Winograd B., Boven E., Lobbezoo M.W., Pinedo H.M. In Vivo. 1:1987;1.
21. Boven E., Winograd B., Berger D.P., Dumont M.P., Braakhuis B.J.M., Fodstad O., Langdon S., Fiebig H.H. Cancer Res. 52:1992;5940.
22. Lelieveld P., van Putten L.M. Cancer Treat. Rep. 60:1976;373.
23. Corbett T.H., Griswold D.P., Roberts B.J., Peckham J.C., Schabel F.M. Cancer. 40:1977;2660.
24. P.J. van Kranenburg-Voogd, H.J. Keizer, L.M. van Putten, Eur. J. Cancer 14 (suppl.) (1978) 153.
25. de Vos D., Willem R., Gielen M., van Wingerden K.E., Nooter K. Met. Based Drugs. 5:1998;179.
26. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. J. Natl. Cancer Inst. 82:1990;1107.
27. Kepers Y.P., Peters G.J., Van Ark-Otte J., Winograd B., Pinedo H.M. Eur. J. Cancer. 27:1991;897.
28. Gielen M. Coord. Chem. Rev. 151:1996;41.
29. Willem R., Dalil H., Broekaert P., Biesemans M., Ghys L., Nooter K., de Vos D., Ribot F., Gielen M. Main Group Met. Chem. 20:1997;535.
30. Gielen M., Ma H., Bouhdid A., Dalil H., Biesemans M., Willem R. Met. Based Drugs. 4:1997;193.
31. Dalil H., Biesemans M., Willem R., Gielen M. Main Group Met. Chem. 21:1998;741.
32. Gielen M., Dalil H., Mahieu B., Biesemans M., Willem R. Appl. Organomet. Chem. 12:1998;855.
33. Gielen M., Dalil H., Biesemans M., Mahieu B., de Vos D., Willem R. Appl. Organomet. Chem. 13:1999;515.
34. Kemmer M., Gielen M., Biesemans M., de Vos D., Willem R. Met. Based Drugs. 5:1998;189.
35. Kemmer M., Ghys L., Gielen M., Biesemans M., Tiekink E.R.T., Willem R. J. Organomet. Chem. 582:1999;195.
36. Susperregui J., Bayle M., Léger J. M., Déléris G., Biesemans M., Willem R., Kemmer M., Gielen M. J. Organomet. Chem. 545-546:1997;559.
37. M. Gielen, in: N.D. Hadjiliadis (Ed.), Cytotoxic, Mutagenic and Carcinogenic Potential of Heavy Metals related to Human Environment, NATO ASI Series 2: Environment, vol. 26, Kluwer, Dordrecht, 1997, pp. 445-455.
38. Gielen M., Willem R., Bouhdid A., de Vos D., Kuiper C.M., Veerman G., Peters G.J. In Vivo. 9:1995;59.
39. Gielen M., El Khloufi A., Biesemans M., Willem R. Appl. Organomet. Chem. 7:1993;119.
40. Gielen M., El Khloufi A., Biesemans M., Kayser F., Willem R. Appl. Organomet. Chem. 7:1993;201.
41. Gielen M., Biesemans M., El Khloufi A., Meunier-Piret J., Kayser F., Willem R. J. Fluorine Chem. 64:1993;279.
42. Gielen M., El Khloufi A., Biesemans M., Bouhdid A., de Vos D., Mahieu B., Willem R. Met. Based Drugs. 1:1994;305.
43. Gielen M., El Khloufi A., de Vos D., Kolker H.J., Schellens J.H.M., Willem R. Bull. Soc. Chim. Belg. 102:1993;761.
44. Gielen M., Bouhdid A., Kayser F., Biesemans M., de Vos D., Mahieu B., Willem R. Appl. Organomet. Chem. 9:1995;251.
45. Gielen M., Tiekink E.R.T., Bouhdid A., de Vos D., Biesemans M., Verbruggen I., Willem R. Appl. Organomet. Chem. 9:1995;639.
46. Gielen M., Willem R., Bouhdid A., de Vos D., Kuiper C.M., Veerman G., Peters G.J. Oncol. Rep. 3:1996;583.
47. Gielen M., Willem R., Dalil H., de Vos D., Kuiper C.M., Peters G.J. Met. Based Drugs. 5:1998;83.